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Abstract : The fast-track surgery protocol, including perioperative immunonutri-
tional management, is increasingly gaining attention for the prevention of surgical 
site infections （SSIs）.  To analyze the association between the fast-track surgery 
protocol employed at a single center and outcomes, including SSIs and the length 
of hospital stays.  This retrospective analysis included 217 patients who underwent 
hepatectomy at the study department between January 2009 and February 2014.  
Patients were divided into two groups : those managed by a conventional protocol 
（group C, n ＝ 75） and those managed by the fast-track surgery protocol （group 
F, n ＝ 142）.  There were no significant differences in patient characteristics or 
factors between the two groups.  However, serum albumin and total cholesterol 
levels before surgery were signicantly higher in group F than in group C, and 
pre-hepatectomy C-reactive protein （CRP） levels were lower in group F than in 
group C.  Moreover, serum albumin and CRP levels at postoperative day 7 were 
better in group F than in group C.  The operations were longer in group F than 
in group C （312 vs. 286 min） and blood loss volume was less （385 g in group F 
vs. 428 g in group C）.  SSI rates were signicantly lower in group F （4.2％, n＝
6） than in group C （13.3％, n＝ 10）, and the length of hospital stay was signi-
cantly shorter in group F （16.7 days） than in group C （25.8 days）.  The fast-track 
surgery protocol as a perioperative management strategy may improve preoperative 
nutritional status and postoperative inammation, with subsequent reductions in SSI 
rates and the length of hospital stay in patients undergoing hepatectomy.
Key words : fast-track surgery, hepatectomy, surgical site infection, immunonutrition, 
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Introduction
　Hepatectomy is a highly invasive surgery compared with other gastroenterological surgeries ; 
the incision tends to be larger during open hepatectomy, bringing an increased risk of several 
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complications.  Surgical site infection （SSI） is one of the most frequent complications of hepa-
tectomy 1-3）.  SSIs can be fatal and are associated with prolonged hospital stays and increased 
medical expenses.  Recently, the “fast-track surgery” protocol, which includes perioperative 
immunonutritional management, has gained attention because of its focus on the prevention of 
SSIs 4-6）.  At our department, the fast-track surgery protocol was introduced in 2011 for patients’ 
early mobilization and discharge5）.  We herein report our retrospective analysis of the validity of 
fast-track surgery and its association with SSIs in our department.
Materials and methods
　The clinical data of 217 patients who underwent hepatectomy at Showa University Hospital 
between January 2009 and February 2014 were retrospectively analyzed.  Patients who underwent 
emergency surgery or surgery for trauma were excluded.  Patients were categorized into group C, 
all 75 consecutive patients who underwent conventional perioperative management in 2009 and 
2010, and group F, all 142 consecutive patients who underwent the fast-track surgery protocol 
after its implementation in 2011.
　The perioperative management, for the conventional protocol and the fast-track surgery proto-
col are presented in Table 1.  A guidebook on liver disease, hepatectomy, and the perioperative 
course was provided to patients while attending the outpatient clinic.  Patients were placed on 
ANOMⓇ oral nutrition （Otsuka Pharmaceutical Factory, Naruto, Japan） and initiated on walk-
ing and breathing training 7 days before surgery.  The day before surgery, the patients took a 
shower, but the hair on the surgical site was not shaved.  No more than 30 min before the skin 
incision, patients were administered 1 g cefmetazole as a surgical antimicrobial prophylaxis, and 
additional doses were administered every 3 h during surgery.  After the surgical incision was closed, 
the subcutaneous tissue was washed with warm saline solution.  Skin closure was achieved with 
subcuticular sutures using 4-0 PDSⓇ （Ethicon） and DuoACTIVEⓇ ET （ConvaTec, Flintshire, UK） 
was used as a sterile dressing for 48 h after the primary closure of skin incision.  In surgeries with 
laparotomy incisions, AQUACELⓇ Ag （ConvaTec） was also used.  Postoperatively, patients resumed 
breathing training using COACH2Ⓡ （Smiths Medical, OH, USA） and walking training; the goal 
for the third day after the operation was 35 laps of the ward （80 m per lap）.  All patients started 
walking and breathing training on postoperative day 1 and peroral feeding on the morning of 
postoperative day 1.  There was no signicant difference between the management of groups C 
and F, except for the above protocols.
　SSIs were dened by following the Centers for Diseases Control and Prevention guidelines 7）. 
Purulent drainage from supercial and deep incisions indicated supercial and deep incisional 
SSIs, respectively.  Moreover, purulent drainage from a drain placed through an incision into the 
organ or space indicated organ/space incisional SSI.
　All values are presented as mean ± standard deviation.  Data were analyzed using the JMPⓇ 
software （version 10.0.0 for Mac; SAS Institute, Cary, NC, USA）.  Individual parameters in the 
two groups were compared using Student’s t test, Welch’s t test, or Pearson’s chi-square test.  p
＜ 0.05 was considered statistically signicant.
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　The Committee on Ethics of Showa University Medical School and Institutional Review Board 
reviewed and approved the study protocols （approval code: No.  3047）.
Results
　There were no signicant differences between group C and group F in patient characteristics 
or tumor-related factors （Tables 2, 3, 4-1 and 4-2）.  Analysis of the preoperative data revealed 
that the mean serum albumin and mean total cholesterol levels were signicantly higher in group 
F than in group C （3.97 vs. 3.71 g/dL and 184 vs. 156 mg/dL, respectively） （Table 2）.  The mean 
C-reactive protein （CRP） of group F （0.58 mg/dL） was lower than that of group C （1.23 mg/
dL）, although this difference was not statistically signicant.  Furthermore, on postoperative day 7, 
the mean serum albumin level was higher, and the mean CRP level was lower in group F than 
in group C, albeit without statistical signicance （Table 2）.
　Next, we analyzed data of only those patients undergoing open hepatectomy （54 patients in 
Table 1
Our fast-track protocol
Days before surgery A guidebook on liver disease, hepatectomy, and the perioperative course was provided 
to patients while attending the outpatient clinic.
Patients took ANOMⓇ for 7 days before their operation.
Patients began breathing training by COACH2Ⓡ 7 days before their operation.
Patients began walking training 7 days before operation.
One day before surgery Patients took a shower, but the hair on the surgical site was not shaved.
The day of surgery No more than 30 min before the skin incision, patients were administered 1 g cefmetazole 
as surgical antimicrobial prophylaxis, and additional doses were administered every 3 h dur-
ing surgery.
After the surgical incision was closed, the subcutaneous tissue was washed with warm 
saline solution.
Skin closure was achieved with subcuticular sutures using 4-0 PDSⓇ （Ethicon）.
DuoACTIVEⓇ ET （ConvaTec, UK） was used as a sterile dressing.
In surgeries with laparotomy incisions, AQUACELⓇ Ag （ConvaTec） was added.
Days after surgery All patients started walking and breathing training on postoperative day 1 and peroral 
feeding on the morning of postoperative day 1.
Conventional protocol
Days before surgery Informed consent about the operation and complications was obtained from patients 
and their family.
One day before surgery Patients took a shower if they needed to.  The hair on the surgical site was shaved.  
The day of surgery No more than 30 min before the skin incision, patients were administered 1 g omoxef so -
dium as a surgical antimicrobial prophylaxis.
After the surgical incision was closed, the subcutaneous tissue was washed with warm 
saline solution.
Days after surgery Patients started walking and breathing training on postoperative day 3 or 4 and peroral 
feeding on the morning of postoperative day 2.
Yuta ENAMI, et al150
group C and 76 patients in group F）.  These ndings are presented in Table 3.  There were no 
signicant differences in the patient characteristics or tumor-related factors.  The mean preopera-
tive serum albumin and total cholesterol levels were significantly higher in group F than in 
group C.  Albeit not statistically signicant, the mean CRP level in group F was lower than that 
in group C.  On postoperative day 7, the mean albumin and CRP levels in group F were higher 
than those in group C, although these differences were not statistically signicant.
　We further analyzed data of only those patients undergoing laparoscopic liver resection （21 
patients in group C and 66 patients in group F）.  These ndings are presented in Table 4-1. 
We did not nd any signicant differences in patient characteristics between the groups except 
Table 2
Characteristics of patients Group C （n＝ 75） Group F （n＝ 142） p value
Sex （male/female）, n 46/29 91/51 0.6912 
Age （years） 67.5 ± 11.0 68.8 ± 9.9 0.3790 
Disease （HCC/meta/others）, n 34/29/12 57/60/25 0.8466 
Number of tumors, n 1.76 ± 1.45 1.61 ± 1.30 0.4432 
Maximum diameter of tumor （mm） 44.4 ± 29.6 44.4 ± 31.3 0.9893 
ICG15R （％） 13.5 ± 8.2 12.6 ± 8.5 0.4775 
Child-Pugh （A/B）, n 69/6 133/9 0.6462 
Laboratory data before operation Group C （n＝ 75） Group F （n＝ 142） p value
Albumin （g/dL） 3.71 ± 0.52 3.97 ± 0.53 0.0005＊
CRP （mg/dL） 1.23 ± 2.75 0.58 ± 1.98 0.0967 
Cholesterol （mg/mL） 156 ± 42.7 184 ± 35.0 0.0002＊
Laboratory data 7 days after operation Group C （n＝ 75） Group F （n＝ 142） p value
Albumin （g/dL） 3.15 ± 0.44 3.25 ± 0.47 0.1459 
CRP （mg/dL） 3.97 ± 4.18 3.21 ± 3.74 0.1776 
Operative variables Group C （n＝ 75） Group F （n＝ 142） p value
Operative time （min） 286 ± 123 312 ± 189 0.2509 
Operative blood loss （g） 428 ± 510 385 ± 624 0.6236 
Rate of laparoscopic surgery （％） 28.0％ （n＝ 21） 46.5％ （n＝ 66） 0.0065＊
Patient outcomes Group C （n＝ 75） Group F （n＝ 142） p value
Rate of SSI （％） 13.3％ （n＝ 10） 4.2％ （n＝ 6） 0.0366＊
Hospital stay （day） 25.8 ± 25.2 16.7 ± 11.0 0.0039＊
Mean ± SD ＊ ; p＜0.05
Group C＝ Conventional protocol 
Group F ＝ Fast-track protocol 
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the mean tumor diameter, which was larger in group F than in group C.  Of the preoperative 
laboratory parameters, the mean total cholesterol level was signicantly higher in group F than 
in group C.  Additionally, the mean preoperative serum albumin level was higher and the CRP 
level was lower in group F than in group C.  Although not statistically signicant, the mean 
serum albumin and CRP levels on postoperative day 7 were better in group F than in group C.
　Further analysis of the operative factors in all patients revealed that the operation time was 
longer and blood loss was less in group F than in group C, although this was not statistically 
signicant （312 vs. 286 min and 385 vs. 428 g, respectively） （Table 2）.  Similarly, among the 
patients who underwent open surgery, the operation time was longer （394 vs. 319 min） and the 
blood loss was less （485 vs. 510 g） in group F than in group C.  Finally, analysis of patients 
Table 3
Characteristics of patients （open surgery） Group C （n＝ 54） Group F （n＝ 76） p value
Sex （male/female）, n 35/19 46/30 0.6223 
Age （years） 68.0 ± 11.6 69.4 ± 8.2 0.4372 
Disease （HCC/meta/others）, n 21/22/11 24/34/18 0.6839 
Number of tumors, n 1.94 ± 1.68 1.96 ± 1.64 0.5165 
Maximum diameter of tumor （mm） 51.3 ± 32.1 49.3 ± 34.3 0.7612 
ICG15R （％） 13.5 ± 8.9 11.9 ± 6.9 0.2569 
Child-Pugh （A/B）, n 49/5 71/5 0.5720 
Laboratory data before operation （open surgery） Group C （n＝ 54） Group F （n＝ 76） p value
Albumin（g/dL） 3.68 ± 0.54 3.94 ± 0.53 0.0075＊
CRP（mg/dL） 1.63 ± 3.22 0.58 ± 2.42 0.0704 
Cholesterol（mg/mL） 161 ± 39.3 192 ± 37.5 0.0024＊
Laboratory data 7 days after operation （open surgery） Group C （n＝ 54） Group F （n＝ 76） p value
Albumin （g/dL） 3.11 ± 0.40 3.15 ± 0.47 0.6251 
CRP （mg/dL） 4.21 ± 4.39 3.88 ± 4.43 0.6770 
Operative variables （open surgery） Group C （n＝ 54） Group F （n＝ 76） p value
Operative time （min） 319 ± 121 394 ± 191 0.0095＊
Operative blood loss （g） 510 ± 559 485 ± 604 0.8128 
Patient outcomes （open surgery） Group C （n＝ 54） Group F （n＝ 76） p value
Rate of SSI （％） 18.5％ （n＝ 10） 6.6％ （n＝ 5） 0.0520 
Hospital stay （day） 28.9 ± 27.2 19.4 ± 11.9 0.0193＊
Mean ± SD ＊ ; p＜0.05
Group C＝ Conventional protocol
Group F ＝ Fast-track protocol
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Table 4-1
Characteristics of patients （laparoscopic surgery） Group C （n＝ 21） Group F （n＝ 66） p value
Sex （male/female）, n 11/10 45/21 0.1921 
Age （years） 66.1 ± 9.6 68.1 ± 11.5 0.4775 
Disease （HCC/meta/others）, n 12/7/2 33/26/7 0.8481 
Number of tumors, n 1.33 ± 0.48 1.19 ± 0.46 0.2659 
Maximum diameter of tumor （mm） 27.7 ± 10.9 38.7 ± 26.6 0.0160＊
ICG15R （％） 13.3 ± 6.3 13.6 ± 10.0 0.9699 
Child-Pugh （A/B）, n 20/1 62/4 0.8238 
Laboratory data before operation （laparoscopic surgery） Group C （n＝ 21） Group F （n＝ 66） p value
Albumin （g/dL） 3.79 ± 0.48 4.02 ± 0.52 0.0790 
CRP （mg/dL） 0.40 ± 1.04 0.57 ± 1.32 0.5937 
Cholesterol （mg/mL） 147 ± 49.5 178 ± 32.1 0.0446＊
Laboratory data 7 days after operation （laparoscopic surgery） Group C （n＝ 21） Group F （n＝ 66） p value
Albumin （g/dL） 3.26 ± 0.53 3.36 ± 0.44 0.3688 
CRP （mg/dL） 3.35 ± 3.62 2.44 ± 2.56 0.2938 
Operative variables （laparoscopic surgery） Group C （n＝ 21） Group F （n＝ 66） p value
Operative time （min） 205 ± 85.8 218 ± 137 0.5987 
Operative blood loss （g） 223 ± 279 264 ± 631 0.6907 
Patient outcomes （laparoscopic surgery） Group C （n＝ 21） Group F （n＝ 66） p value
Rate of SSI （％） 0％ （n＝ 0） 1.5％ （n＝ 1） 0.5757 
Hospital stay （day） 17.8 ± 17.6 13.7 ± 9.2 0.3241 
Mean ± SD ＊ ; p＜0.05
Group C＝ Conventional protocol 
Group F＝ Fast-track protocol 
Table 4-2






Rate of SSI （％） 6.6％ （n＝ 5） 1.5％ （n＝ 1） 0.1701 
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undergoing laparoscopic surgery also revealed that there was a tendency for longer operation 
times but in this case more blood loss in group F than in group C （218 vs. 205 min and 264 vs. 
223 g, respectively） （Table 4-1）.  Considering all patients, the rates of laparoscopic surgery were 
signicantly higher in group F than group C （46.5％ and 28.0％ , respectively） （Table 2）.
　SSI rates were signicantly lower in group F than group C, being 4.2％ （n＝ 6） and 13.3％ 
（n＝ 10）, respectively （Table 2）.  All patients with SSIs in group C and ve of the six patients 
with SSIs in group F had undergone open surgery.  Limiting the analysis of SSIs to the subset 
of patients undergoing open surgery revealed that there were fewer SSIs in group F than in 
group C （6.6％ （n＝ 5） vs. 18.5％ （n＝ 10）, p＝ 0.052） （Table 3）.  Finally, only one patient 
undergoing laparoscopic hepatectomy in group F had an SSI, and no patients undergoing laparo-
scopic hepatectomy in group C developed SSIs （Table 4-1）.  There was no signicant difference 
between open surgery and laparoscopic surgery in the rate of SSI in group F （Table 4-2）.
　The length of hospital stay was signicantly shorter in group F than in group C （16.7 vs. 25.8 
days, respectively） （Table 2）.  This nding held true in the patients undergoing open surgery 
（group F 19.4 vs. group C 28.9 days; p＝ 0.0193） （Table 3）.  Among the patients undergoing 
laparoscopic surgery, the length of hospital stay, albeit shorter in group F than in group C, did 
not signicantly differ between the two groups （Table 4-1）.  
　Evaluation of factors associated with SSIs by multivariate analysis revealed that preoperative 
serum albumin was the only risk factor for SSIs in the study cohort （Table 5）.
Discussion
　The aim of the present study was to determine whether the fast-track surgery protocol 
employed at our department with perioperative management including immunonutrition pre-
vented SSIs after hepatectomy.  Our analysis revealed that SSI rates were signicantly lower 
and the length of hospital stay was signicantly shorter in patients who were managed by the 
fast-track surgery protocol.  Previous studies have reported several factors, including periopera-
tive nutritional status, liver function, operation time, blood loss, repeat hepatectomy, and bile 
stula, as risk factors for SSIs after hepatectomy 1-3, 8）.  In the present study, preoperative serum 
albumin and total cholesterol levels were signicantly better in the fast-track group than in the 
conventional group, suggesting the possibility that the administration of immunonutrition for 
preoperative patients in the fast-track group causes the elevation of these values.  Serum albumin 
and total cholesterol levels reect nutritional status and might have contributed to the prevention 
of SSIs.  The study results indicate that the preoperative management including oral immuno-
Table 5
Multivariate analysis of SSI risk factors in all patients
Variables Odds ratio 95％ Condence intervals p value
Perioperative albumin value 0.071276 0.006459-0.786486 0.0244＊
Perioperative cholesterol value 12.80627 0.998147-1.020609 0.0863
＊ ; p＜0.05
Yuta ENAMI, et al154
nutrition employed at our department was successful in preventing SSIs.  Several meta-analyses 
have previously indicated that preoperative immunonutrition is an excellent approach to prevent 
infectious complications after elective surgery and to shorten the length of hospital stays 9, 10）, but 
despite abundant information regarding its utility in gastrointestinal surgery, data on its efcacy 
in liver surgery are limited.  In a clinical study on liver transplantation surgery, immunonutri-
tion was shown to reduce postoperative infectious complications 11）, and several studies suggest 
its efcacy in preoperative venous or oral nutritional management 12-17）.  The ESPEN guidelines 
recommend immunonutritional therapy for major surgery with a high risk of infection, regardless 
of nutritional risk, and recommend starting this therapy 5-7 days before elective surgery 18）.  In 
previous reports, the administration of 220-1,000 mL/day of immune-enhancing diet （IED） from 
5 days to 3 weeks before surgery reduced CRP after hepatectomy 17） and risk of infection after 
gastric19） and colorectal 20） operations.  It is reported that such diets are useful for reducing infec-
tious diseases.  We therefore hypothesized that we could reduce the risk of developing infectious 
complications after hepatectomy by administering 200-600 mL/day of ANOMⓇ as an IED from 7 
days before surgery.
　In the present study, we implemented perioperative management including oral immunonutri-
tion before hepatectomy.  The signicantly better preoperative serum albumin and total choles-
terol levels we found as indices of nutritional status 21） might be associated with the lower SSI 
rates and shorter hospital stays in patients managed by the fast-track surgery protocol.  More-
over, improvements in preoperative inammatory changes may contribute to the improvement of 
nutritional status.  High preoperative CRP levels and hypoalbuminemia were previously reported 
to be poor prognostic factors in hepatectomy 22）.  Therefore, perioperative management including 
oral immunonutrition should be considered as a useful approach to control high CRP levels and 
hypoalbuminemia.
　In the present study, patients were started on ANOMⓇ 7 days before surgery as an addition 
to their normal diet.  ANOMⓇ contains 20％ protein and 25％ lipids, wherein percentages reect 
the energy density.  And it contains glutamine and arginine as amino acids, and the lipids are 
ω-3 and ω-6 fatty acids （with a ratio of 1：2）.  The primary ω-3 fatty acid in ANOMⓇ is α
-linolenic acid, which is present in ANOMⓇ at a higher percentage than either eicosapentaenoic 
acid （EPA） or docosahexaenoic acid （DHA） （Table 6）.  α-Linolenic acid is the precursor of 
EPA and DHA, which have anti-inammatory functions by suppressing the arachidonic cascade, 
i.e., the production and subsequent effect of inammatory eicosanoids.  One study reported that 
parenteral nutrition supplemented with the emulsion of sh oil, which includes EPA and DHA 
rich in ω-3 fatty acids, reduced systemic inammatory response syndrome and the length of hos-
pital stays in patients with gastric and colonic cancer 23）.  In the present study, the improvement 
in immunocompetence and observed anti-inammatory effects reected by higher serum albumin 
and lower CRP levels might be due to the oral intake, and several reports indicated that pre-
operative nutritional condition could be improved by the oral administration of immunonutrition. 
Moreover, in the present study, our perioperative management was associated with reduced SSI 
rates and shorter length of hospital stays, and perioperative serum albumin level was signicantly 
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associated with the reduced SSI rates after hepatectomy by the multivariate analysis.  Future 
studies are warranted to reveal the specic nutritional components associated with this outcome.
　In the study cohort, the rate of laparoscopic hepatectomy was significantly higher in the 
fast-track group than in the conventional group, which might be the main contributor to the 
improved SSI rate found in the fast-track group.  A previous study has suggested that laparo-
scopic hepatectomy might be a factor of reducing SSI 24）, but the length of hospital stays, pre-
operative serum albumin, and total cholesterol levels did not signicantly differ between patients 
using the fast-track or conventional protocol within the subset undergoing laparoscopic surgery. 
One potential reason for this outcome is that almost all patients undergoing laparoscopic surgery 
were in a moderately good clinical condition preoperatively during the time period when the 
conventional method was used for their management.  Conversely, the rate of SSI in the open 
surgery subset in the conventional protocol may be acceptable based on previous reports show-
ing that the rate of SSI in open hepatectomy was 24.8％ （29/117）24） and the complication rate 
was 27％ （129/474）25）.  In the present study, in the subset of patients undergoing open surgery, 
the hospital stay was signicantly shorter and the SSI rate was lower （p＝ 0.052） in the fast-
track group than the conventional group, which might reect a signicantly better preoperative 
nutritional status in these patients, although the operation time was longer in patients undergoing 
open surgery with the fast-track protocol.  Overall, improvement of the preoperative nutritional 
status by oral administration might have contributed to the reduced SSI rate despite the longer 
operation time, particularly among patients undergoing open surgery.
　Postoperative fast-track program and enhanced recovery after surgery are recently proposed 
perioperative management approaches that have been increasingly used worldwide 4-6）.  Initially 
used primarily in patients undergoing colon surgery, these protocols have also been successfully 
used in gastric and breast surgery 26-28）.  Although there have been only a small number of 
studies on liver surgery, these protocols have been found to be feasible and effective after liver 
Table 6
Component composition of ANOM Amount per 100g
Energy （kcal） 100 100％
Protein （g） 5 20％
 Glutamine （g）  0.75
 Arginine （g）  0.46
Fat （g） 2.8 25％
 ω-6 Fatty acid family （g）  0.29 2.61％
 （Linoleic acid） 2.61％
 ω-3 Fatty acid family （g）  0.15 1.35％
 （α-Linolenic acid） 1.04％
 （Eicosapentaenoic acid） 0.18％
 （Docosahexaenoic acid） 0.12％
 ω-6：ω-3 2：1
％ : the rate of energy
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resection 25）.  In the present study, all patients were provided information regarding the surgery 
and protocols before surgery, and walking and breathing training was started 7 days before 
surgery.  Moreover, patients were started on oral nutrition as well as walking and breathing 
training on postoperative day 1.  We had induced and performed the fast-track protocol, includ-
ing management of the closing incision.  Therefore, several factors might have contributed to the 
prevention of SSIs.  We can conclude that the implementation of the fast-track surgery protocol 
at our department was safe, with no mortality, and might have greatly contributed to the short-
ening of the postoperative hospitalization period and reduction of SSI rates.  However, this was 
a retrospective study including patients with different etiologies ranging from metastatic liver 
tumor to hepatocellular carcinoma.  Whether the fast-track surgery protocol implemented at our 
department can be introduced to all patients, including those with poor liver function, requires 
further studies with larger patient cohorts.
　The limitations of our study are that the analysis was limited to a single institution and that 
the study had a retrospective design.  Further analysis and more patients are needed to conrm 
the effect of our protocol.
Conclusion
　The fast-track surgery protocol including perioperative management with walking and breathing 
training and preoperative nutrition is a feasible and safe approach that can improve preoperative 
nutritional status, particularly preoperative albumin level, and postoperative inammation, thereby 
contributing to reduced SSI rates and shorter hospital stays in patients undergoing hepatectomy.
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